Fresenius sees Akorn lawsuit dragging on into 2019

Reuters Staff

2 Min Read

BERLIN (Reuters) - German healthcare group Fresenius SE (FREG.DE) said on Thursday its legal battle with Akorn (AKRX.O) over its canceled $4.7 billion takeover could drag on into 2019 as it posted a slight decline in quarterly profit hurt by a strong euro.